IPW
RCUS icon

Impact Partnership Wealth’s Arcus Biosciences RCUS Stock Holding History

Impact Partnership Wealth’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-37
Closed -$751 – 1162
2023
Q2 		$751 Buy
+37
New +$705 ﹤0.01% 831

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Impact Partnership Wealth's RCUS Position: Q3 2023 in Review

Impact Partnership Wealth sold out of Arcus Biosciences (RCUS) in Q3 2023, closing a stake of 37 shares — an estimated $751 sold.

Impact Partnership Wealth first reported a position in RCUS in Q2 2023 and held it in 1 quarter. The position peaked at $751 in Q2 2023. 187 funds tracked by Wall St. Rank hold RCUS as of Q3 2023.

  • Impact Partnership Wealth reported no remaining Arcus Biosciences position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 37 Arcus Biosciences shares in Q3 2023, an estimated $751.
  • Impact Partnership Wealth first reported a position in Arcus Biosciences in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's Arcus Biosciences position peaked at $751 in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.